379 related articles for article (PubMed ID: 12852237)
1. Canine mammary gland tumors.
Sorenmo K
Vet Clin North Am Small Anim Pract; 2003 May; 33(3):573-96. PubMed ID: 12852237
[TBL] [Abstract][Full Text] [Related]
2. Influence of host factors on survival in dogs with malignant mammary gland tumors.
Philibert JC; Snyder PW; Glickman N; Glickman LT; Knapp DW; Waters DJ
J Vet Intern Med; 2003; 17(1):102-6. PubMed ID: 12564734
[TBL] [Abstract][Full Text] [Related]
3. Quantitation of the Regional Lymph Node Metastatic Burden and Prognosis in Malignant Mammary Tumors of Dogs.
de Araújo MR; Campos LC; Ferreira E; Cassali GD
J Vet Intern Med; 2015; 29(5):1360-7. PubMed ID: 26130166
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of histologic stage and proliferative activity in canine malignant mammary tumors.
Sarli G; Preziosi R; Benazzi C; Castellani G; Marcato PS
J Vet Diagn Invest; 2002 Jan; 14(1):25-34. PubMed ID: 12680640
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of hormone receptor expression for use in predicting survival of female dogs with malignant mammary gland tumors.
Chang CC; Tsai MH; Liao JW; Chan JP; Wong ML; Chang SC
J Am Vet Med Assoc; 2009 Aug; 235(4):391-6. PubMed ID: 19681719
[TBL] [Abstract][Full Text] [Related]
6. Prognostic Significance of Canine Mammary Tumor Histologic Subtypes: An Observational Cohort Study of 229 Cases.
Rasotto R; Berlato D; Goldschmidt MH; Zappulli V
Vet Pathol; 2017 Jul; 54(4):571-578. PubMed ID: 28355108
[TBL] [Abstract][Full Text] [Related]
7. Improving the diagnosis and treatment of canine mammary tumours: Immunohistochemical markers as prognostic tools.
Morris JS
Vet J; 2010 Apr; 184(1):3-4. PubMed ID: 19713137
[No Abstract] [Full Text] [Related]
8. Principles of treatment for mammary gland tumors.
Novosad CA
Clin Tech Small Anim Pract; 2003 May; 18(2):107-9. PubMed ID: 12831071
[TBL] [Abstract][Full Text] [Related]
9. CD44 and CD24 Expression and Prognostic Significance in Canine Mammary Tumors.
Rogez B; Pascal Q; Bobillier A; Machuron F; Lagadec C; Tierny D; Le Bourhis X; Chopin V
Vet Pathol; 2019 May; 56(3):377-388. PubMed ID: 30558511
[TBL] [Abstract][Full Text] [Related]
10. Canine Mammary Tumors: Comparison of Classification and Grading Methods in a Survival Study.
Canadas A; França M; Pereira C; Vilaça R; Vilhena H; Tinoco F; Silva MJ; Ribeiro J; Medeiros R; Oliveira P; Dias-Pereira P; Santos M
Vet Pathol; 2019 Mar; 56(2):208-219. PubMed ID: 30381007
[TBL] [Abstract][Full Text] [Related]
11. Prognostic factors associated with survival two years after surgery in dogs with malignant mammary tumors: 79 cases (1998-2002).
Chang SC; Chang CC; Chang TJ; Wong ML
J Am Vet Med Assoc; 2005 Nov; 227(10):1625-9. PubMed ID: 16313041
[TBL] [Abstract][Full Text] [Related]
12. Prognostic studies of canine and feline mammary tumours: the need for standardized procedures.
Matos AJ; Baptista CS; Gärtner MF; Rutteman GR
Vet J; 2012 Jul; 193(1):24-31. PubMed ID: 22296767
[TBL] [Abstract][Full Text] [Related]
13. Ki-67 and PCNA Expression in Canine Mammary Tumors and Adjacent Nonneoplastic Mammary Glands: Prognostic Impact by a Multivariate Survival Analysis.
Carvalho MI; Pires I; Prada J; Lobo L; Queiroga FL
Vet Pathol; 2016 Nov; 53(6):1138-1146. PubMed ID: 27162119
[TBL] [Abstract][Full Text] [Related]
14. Expression and prognostic value of c-met in canine mammary tumours.
Chen YC; Chen YY; Liao JW; Chang SC
Vet Comp Oncol; 2018 Dec; 16(4):670-676. PubMed ID: 30129270
[TBL] [Abstract][Full Text] [Related]
15. Clinical and pathological prognostic factors in canine mammary tumors.
Pérez Alenza MD; Peña L; Nieto AI; Castaño M
Ann Ist Super Sanita; 1997; 33(4):581-5. PubMed ID: 9616968
[TBL] [Abstract][Full Text] [Related]
16. Immunocytochemical study of Ki-67 as a prognostic marker in canine mammary neoplasia.
Zuccari DA; Santana AE; Cury PM; Cordeiro JA
Vet Clin Pathol; 2004; 33(1):23-8. PubMed ID: 15048623
[TBL] [Abstract][Full Text] [Related]
17. Matrix metalloproteinase-9 expression in mammary gland tumors in dogs and its relationship with prognostic factors and patient outcome.
Santos AA; Lopes CC; Marques RM; Amorim IF; Gärtner MF; de Matos AJ
Am J Vet Res; 2012 May; 73(5):689-97. PubMed ID: 22533401
[TBL] [Abstract][Full Text] [Related]
18. Postoperative adjuvant treatment of invasive malignant mammary gland tumors in dogs with doxorubicin and docetaxel.
Simon D; Schoenrock D; Baumgärtner W; Nolte I
J Vet Intern Med; 2006; 20(5):1184-90. PubMed ID: 17063714
[TBL] [Abstract][Full Text] [Related]
19. Development, anatomy, histology, lymphatic drainage, clinical features, and cell differentiation markers of canine mammary gland neoplasms.
Sorenmo KU; Rasotto R; Zappulli V; Goldschmidt MH
Vet Pathol; 2011 Jan; 48(1):85-97. PubMed ID: 21147765
[TBL] [Abstract][Full Text] [Related]
20. Postoperative treatment outcome in canine mammary tumors. Multivariate analysis of the prognostic value of pre- and postoperatively available information.
Betz D; Schoenrock D; Mischke R; Baumgärtner W; Nolte I
Tierarztl Prax Ausg K Kleintiere Heimtiere; 2012; 40(4):235-42. PubMed ID: 22911254
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
